TABLE 2 Histopathologic findings
Variable Type of hysteroscopy Type of hysteroscopy Type of hysteroscopy p-value
Office (n = 222) OR (n = 355) Repeat (n = 53)
Tissue sampling during procedure, n (%) 130 (58.6) 335 (94.4) 48 (90.6) <0.001
Histologic report, n (%) Benign Abnormal Premalignant a Malignant b Non-diagnostic 107 (82.3) 19 (14.6) 6 (4.6) 13 (10) 4 (3.1) 228 (68.1) 79 (23.6) 16 (4.8) 63 (18.8) 28 (8.3) 35 (72.9) 12 (25.0) 3 (6.2) 9 (18.8) 1 (2.1) 0.009 0.087 0.050
a Including hyperplasia or complex hyperplasia without atypia (n = 13), metaplasia/hyperplasia/complex hyperplasia with atypia (n = 10), atypical leiomyoma (n = 1), intrafallopian intraepithelial serous adenocarcinoma (n = 1). b Including endometrial carcinoma (Figo 1-3; n = 63), uterine sarcoma (n = 10), squamous cell carcinoma of vagina or cervix (n = 8), metastases (primary melanoma, colorectal carcinoma; n = 4). a Including hyperplasia or complex hyperplasia without atypia (n = 13), metaplasia/hyperplasia/complex hyperplasia with atypia (n = 10), atypical leiomyoma (n = 1), intrafallopian intraepithelial serous adenocarcinoma (n = 1). b Including endometrial carcinoma (Figo 1-3; n = 63), uterine sarcoma (n = 10), squamous cell carcinoma of vagina or cervix (n = 8), metastases (primary melanoma, colorectal carcinoma; n = 4). a Including hyperplasia or complex hyperplasia without atypia (n = 13), metaplasia/hyperplasia/complex hyperplasia with atypia (n = 10), atypical leiomyoma (n = 1), intrafallopian intraepithelial serous adenocarcinoma (n = 1). b Including endometrial carcinoma (Figo 1-3; n = 63), uterine sarcoma (n = 10), squamous cell carcinoma of vagina or cervix (n = 8), metastases (primary melanoma, colorectal carcinoma; n = 4). a Including hyperplasia or complex hyperplasia without atypia (n = 13), metaplasia/hyperplasia/complex hyperplasia with atypia (n = 10), atypical leiomyoma (n = 1), intrafallopian intraepithelial serous adenocarcinoma (n = 1). b Including endometrial carcinoma (Figo 1-3; n = 63), uterine sarcoma (n = 10), squamous cell carcinoma of vagina or cervix (n = 8), metastases (primary melanoma, colorectal carcinoma; n = 4). a Including hyperplasia or complex hyperplasia without atypia (n = 13), metaplasia/hyperplasia/complex hyperplasia with atypia (n = 10), atypical leiomyoma (n = 1), intrafallopian intraepithelial serous adenocarcinoma (n = 1). b Including endometrial carcinoma (Figo 1-3; n = 63), uterine sarcoma (n = 10), squamous cell carcinoma of vagina or cervix (n = 8), metastases (primary melanoma, colorectal carcinoma; n = 4).